Leadership & Pay ·
Amgen CTO David Reese retires June 30 as company redistributes responsibilities to integrate science, technology, and data functions
AMGNAmgen Inc
Amgen Inc. announced that David M. Reese will retire as Executive Vice President and Chief Technology Officer on June 30, 2026. His responsibilities will be redistributed among the heads of R&D, Global Markets and Policy, and the CFO starting June 1, 2026, to better integrate the company's science, technology, and data functions. This leadership transition signals a structural reorganization of technology and data oversight across Amgen's senior management.